Anti-TPO Antibody Unit Converter
Anti-TPO Antibody Unit Converter
IU/mL, kIU/L and U/mL are the same number for thyroid peroxidase antibodies — convert between them, and then note the thing that matters more than any conversion: results from different assays cannot be compared with each other at all.
Anti-TPO Antibody converter
IU/mL = kIU/LAnti-TPO 35 IU/mL
The units are interchangeable; the results are not
1 IU/mL = 1,000 IU/L
and no conversion exists between one manufacturer’s IU/mL and another’s
- IU/mL = kIU/L = U/mL
- the same number. A thousand international units in a litre is one in a millilitre, and manufacturers who write U/mL rather than IU/mL mean the same arbitrary unit
- IU/L
- the IU/mL figure multiplied by a thousand, so 35 IU/mL is 35,000 IU/L. Rarely used for this analyte, and worth checking when a titre looks implausibly large
- an arbitrary unit
- there is no mass or molar equivalent. The "international unit" here refers to calibration against a reference preparation, but each manufacturer sets up its own calibration with its own antigen preparation and its own epitope mix — so the unit is arbitrary in the strict sense
- the consequence
- published cut-offs across commercial assays span roughly an order of magnitude. A result of 35 IU/mL may be four times the cut-off on one platform and below it on another, and a change from 35 to 120 across two laboratories may mean nothing at all
Worked example
Anti-TPO 35 IU/mL
35 IU/mL = 35.0 kIU/L = 35.0 U/mL = 35,000 IU/L — one result, four ways of writing it
Now the only question that matters: which assay produced it, and what is that assay's cut-off? On Mayo's platform, where the reference value is <9.0 IU/mL, 35 is clearly positive. On a platform whose cut-off is 60 IU/mL, the same serum could be reported as negative
So a previous result of 15 IU/mL from a different laboratory tells you nothing about whether the antibody has risen. A numerical change is only a change when both numbers came from the same method
And a positive result is not a diagnosis. Roughly one person in ten in the general population is TPO antibody-positive without thyroid disease, more commonly women and with increasing age
What the result does is attribute: in a patient whose TSH is raised, a positive anti-TPO says the cause is autoimmune. It does not by itself say anyone needs treating
Where an anti-TPO changes management, and where it does not
| Situation | Does the antibody help? |
|---|---|
| Raised TSH — establishing the cause of hypothyroidism | Yes. A positive result attributes it to autoimmune thyroiditis, which is the commonest cause in iodine-replete populations |
| Subclinical hypothyroidism — estimating the risk of progression | Yes. In the Whickham 20-year follow-up the annual risk of developing hypothyroidism in women was roughly 4% where both TSH was raised and antibodies were positive, against about 2–3% with either alone |
| Pregnancy or planned pregnancy with a raised TSH, and after delivery | Yes. Antibody positivity carries a higher risk of gestational thyroid dysfunction and of postpartum thyroiditis, and influences monitoring |
| A euthyroid patient with a normal TSH and no symptoms | Rarely. A positive result identifies a risk of future hypothyroidism but neither diagnoses disease nor justifies treatment; it mainly commits the patient to periodic TSH measurement |
| Monitoring known autoimmune thyroid disease | No. The titre does not track thyroid function or guide levothyroxine dosing, and there is no value in repeating it. TSH is the monitoring test |
| Distinguishing Graves’ disease from other causes of thyrotoxicosis | Not the right antibody. Anti-TPO is positive in a majority of Graves’ patients but is not specific; the TSH receptor antibody is the test for that question |
Why a positive anti-TPO is not a diagnosis
| Observation | Figure | Source |
|---|---|---|
| Thyroid peroxidase antibodies in the disease-free US population | About 11%, rising with age and roughly two to three times more common in women; detectable antibodies in people without thyroid disease occur at the same frequency as in non-immune thyroid disease | NHANES III, and Mayo’s own interpretive comment quoting 10–12% |
| Mayo Clinic Laboratories reference value, chemiluminometric immunoassay | <9.0 IU/mL, applying to all ages; values above that generally associated with autoimmune thyroiditis but also seen in other autoimmune disease | Mayo test TPO |
| Spread of cut-offs across commercial platforms | Roughly an order of magnitude between methods, despite nominal international units | Assay-specific; this is why no interval is printed on this page |
An arbitrary unit, and a result that belongs to its assay
Thyroid peroxidase antibodies are reported in international units per millilitre, in kilo-international units per litre or occasionally in units per millilitre, and all three are the same number: a thousand units in a litre is one unit in a millilitre. Units per litre, where they are used, are the IU/mL figure multiplied by a thousand. There is no mass or molar equivalent, because what is being measured is binding activity against an antigen preparation rather than a defined quantity of a defined molecule.
That last point is the substance of this page. The “international” in international unit implies a common calibration, and there is a reference preparation, but each manufacturer builds its assay with its own thyroid peroxidase antigen, its own solid phase and its own epitope mix, and calibrates to its own working standard. Published cut-offs across commercial platforms consequently span roughly an order of magnitude. A result of 35 IU/mL is unambiguously positive against Mayo’s reference value of less than 9.0 IU/mL, and could be reported as negative by a method whose threshold is 60. It follows that a numerical change between two results means nothing unless both came from the same assay in the same laboratory — and that is why this page prints no reference interval under the converted answer. There is no interval that belongs to the analyte rather than to the instrument.
What the antibody is good for is attribution. In a patient whose TSH is raised, a positive anti-TPO identifies autoimmune thyroiditis as the cause, which in iodine-replete populations is the commonest one. In subclinical hypothyroidism it helps quantify the risk of progression: the Whickham 20-year follow-up found an annual risk of developing hypothyroidism in women of roughly 4% where both the TSH was raised and antibodies were present, against about 2 to 3% with either finding alone. In pregnancy, antibody positivity raises the risk of gestational thyroid dysfunction and of postpartum thyroiditis and changes how closely a patient is followed.
What it cannot do is make a diagnosis by itself. Thyroid peroxidase antibodies are present in about one in ten of the disease-free population — more often in women, and more often with increasing age — so a positive result in someone with a normal TSH and no symptoms identifies a risk of future thyroid failure rather than a disease, and it does not justify treatment. Nor is there any value in repeating it: the titre does not track thyroid function, does not guide levothyroxine dosing and does not need monitoring. TSH is the test that does that work. And where the question is whether a thyrotoxic patient has Graves’ disease, the relevant antibody is the TSH receptor antibody, not this one.
Frequently asked questions
Is 35 IU/mL of anti-TPO the same as 35 kIU/L?
Yes — IU/mL, kIU/L and U/mL are numerically identical, so no conversion is needed between them. IU/L, which is occasionally used, is the IU/mL figure multiplied by a thousand, so 35 IU/mL is 35,000 IU/L. There is no molar or mass unit, because the assay measures binding activity against an antigen preparation rather than a defined quantity of a defined molecule.
Can anti-TPO results from two different laboratories be compared?
No. Each manufacturer uses its own antigen preparation, solid phase and calibration, so despite the nominal international unit the published cut-offs across commercial assays differ by roughly an order of magnitude. A result of 35 IU/mL can be clearly positive on one platform and below the threshold on another, and an apparent rise between two laboratories may be entirely an artefact of the change of method. Compare results only within one assay in one laboratory.
Why does this page show no reference interval?
Because the cut-off is a property of the assay rather than of the patient. Mayo’s chemiluminometric method reports a reference value of less than 9.0 IU/mL; other platforms publish thresholds several times higher or lower. Printing one of them under the answer would license exactly the comparison this page exists to warn against — reading a number from one laboratory against a threshold from another. Mayo’s value is tabulated above and named as theirs.
Does a positive anti-TPO mean I have thyroid disease?
Not on its own. Roughly one person in ten in the disease-free population carries thyroid peroxidase antibodies, more commonly women and more commonly with increasing age. With a normal TSH and no symptoms, a positive result marks an increased risk of developing hypothyroidism in future rather than a current disease, and it is not a reason for treatment. Where the TSH is already raised, a positive antibody attributes the hypothyroidism to autoimmune thyroiditis.
Should anti-TPO be repeated to monitor thyroid disease?
No. The titre does not track thyroid function, does not guide levothyroxine dosing and has no monitoring role — TSH does that job. Repeating the antibody is the commonest misuse of the assay, and it is doubly unhelpful when the follow-up sample goes to a different laboratory, because the two numbers are then not comparable at all.
Related calculators
References
- Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489–499. doi:10.1210/jcem.87.2.8182
- Vanderpump MPJ, Tunbridge WMG, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995;43(1):55–68.
- Mayo Clinic Laboratories. Test ID: TPO — Thyroperoxidase (TPO) Antibodies, Serum. Chemiluminometric immunoassay. Reference value <9.0 IU/mL, applying to all ages; detectable antibodies occur in 10–12% of people without thyroid disease.
- Baloch Z, Carayon P, Conte-Devolx B, et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid. 2003;13(1):3–126 — method-dependence of thyroid autoantibody measurement.
Medical Disclaimer: The tools and content provided here are for educational and reference purposes only. They are not intended to substitute for professional medical advice, diagnosis, or treatment. Clinical decisions should always be based on the comprehensive assessment of a qualified healthcare professional.